Intero Biosystems wants drugmakers to test on mini human intestines, not animals

Key points

• Intero Biosystems, a Denver-based startup, is developing human intestinal organoids, lab-grown tissue that mimics the gut, as another way to study how drugs and other compounds might affect the human body before they are tested in people.
• The startup’s flagship product, GastroScreen, is a human intestinal organoid model that it sells to pharmaceutical, biotech, food, and chemical companies for testing drugs and other compounds.
• Customers can use them as healthy intestinal models or induce disease-like conditions to test how the tissue responds to different compounds.

Sentences selected automatically from the original article by TechCrunch.